advertisement
Abstract #17961 Published in IGR 9-2
Latanoprost-related transient incontinence
Raja V; Sandanshiv P; Asghar M; Moriarty BClinical and Experimental Ophthalmology 2007; 35: 389-390
Latanoprost has increasingly become the first choice in topical anti-glaucoma therapy. Local adverse events like hypertrichosis and increased iris pigmentation are common whereas systemic adverse events have been rare and mild in intensity. The authors would like to report a case of transient urge incontinence after initiation of latanoprost therapy confirmed by challenge-rechallenge tests and speculate on the causal relationship.
Dr. V. Raja, The Eye Care Centre, Leighton Hospital, Crewe, UK
Classification:
11.4 Prostaglandins (Part of: 11 Medical treatment)
